EPIGENOMICS AG Inactive Instrument
Company Epigenomics AG Xetra
Equities
DE000A1K0516
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
Business Summary
Sales per Business
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
In Vitro Diagnostic - Products
95.9
%
| 0 | 7.5 % | 0 | 95.9 % | 0.00% |
Licensing
4.1
%
| 0 | 0.4 % | 0 | 4.1 % | -9.09% |
Sales per region
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
North America
54.2
%
| 0 | 4.8 % | 0 | 54.2 % | -11.45% |
Europe
38.6
%
| 0 | 3.0 % | 0 | 38.6 % | -1.06% |
Asia
7.2
%
| 6 | 92.2 % | 0 | 7.2 % | -99.39% |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 875,150 | 584,339 ( 66.77 %) | 0 | 66.77 % |
Company contact information
Sector
Sales per Business
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| -20.45% | 10.67B | |
| +43.17% | 3.22B | |
| -35.86% | 2.09B | |
| -17.21% | 2.04B | |
| -29.81% | 1.46B | |
| +17.56% | 1B | |
| -4.37% | 734M | |
| -37.00% | 391M | |
| -46.94% | 379M |
- Stock Market
- Equities
- ECX Stock
- Stock
- Company Epigenomics AG
